

Pharvaris, a drug developer, has raised $80 million in Series C financing. Viking Global Investors and General Atlantic led the round.
Source: Press Release
Pharvaris, a drug developer, has raised $80 million in Series C financing.
Pharvaris, a drug developer, has raised $80 million in Series C financing. Viking Global Investors and General Atlantic led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination